JOEP MUIJRERS, PHD
Joep Muijrers, PhD, is the Chief Financial Officer at PureTech Health. Dr. Muijrers has two decades of experience in corporate and capital finance, specifically focused on public market investment, M&A, portfolio management, strategic asset allocation, financial and regulatory reporting, and fundraising. Prior to joining PureTech Health, he was a Portfolio Manager and Partner at LSP (Life Sciences Partners), a trans-Atlantic investor group with exclusive focus on life sciences. At LSP, Dr. Muijrers was responsible for investing in publicly-traded companies, a strategy that generated a total return in excess of 900%, more than twice the return of the Nasdaq Biotechnology Index during the same period (Q2 2008 - Q1 2018). Notable investments included companies that were acquired by large pharma (Ablynx, Colucid, InterMune, Kite Pharma, NeuroDerm) and/or became leaders in their respective areas of activity (Evotec, Genmab, GW Pharmaceuticals, MorphoSys, Neurocrine). Prior to joining LSP, he held the position of Director Corporate Finance and Capital Markets at Fortis Bank, currently part of ABN AMRO. Dr. Muijrers holds a PhD degree in Molecular Biology from the European Molecular Biology Laboratory (EMBL) in Heidelberg, Germany and a Master’s degree in Biochemistry from the University of Nijmegen, The Netherlands.